Use of assisted reproductive technology to prevent the transmission of HIV-1 in HIV-discordant couples desiring children

Immunology and Allergy Clinics of North America

Volumn 22, Issue 3, 2002, Pages 663-679

  Politch, Joseph A ^a   Anderson, Deborah J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTIFICIAL INSEMINATION; DENDRITIC CELL; FEMALE; GENITAL TRACT INFECTION; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION RISK; INFECTION SENSITIVITY; MALE; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SEXUALLY TRANSMITTED DISEASE; T LYMPHOCYTE; VIRUS EXPRESSION; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 0036694998     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(02)00020-6     Document Type: Article

References (136)

1. Anonymous. AIDS epidemic update. UNAIDS Joint United Nations Programme on HIV/AIDS. Geneva: UNAIDS/WHO; 2001.
2. Fowler MG, Melnick SL, Mathieson BJ. Women and HIV: epidemiology and global overview. Obstet Gynecol Clin North Am 1997;24:705-729.
3. Vernazza PL, Gilliam BL, Dyer J, et al. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS 1997;11:987-93.
4. Panther LA, Tucker L, Xu C, et al. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV env diversity in perinatal HIV-1 transmission. J Infect Dis 2000;181:555-63.
5. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001;357: 1149-53.
6. Padian NS, Shiboski SC, Glass SO, et al. Heterosexual transmission of human immunodeficiency virus (HIV) in Northern California: results from a ten-year study. Am J Epidemiol 1997; 146:350-7.
7. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000;342:921-9.
8. Peckham C, Gibb D. Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med 1995;333:298-302.
9. Downs AM, de Vincenzi I. Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. J Acquir Immune Defic Syndr 1996;11:388-95.
10. Peterman TA, Stoneburner RL, Allen JR, et al. Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. JAMA 1988;259:55-8.
11. Chakraborty H, Sen PK, Helms RW, et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 2001;15:621-7.
12. Gray RH, Kiwanuka N, Quinn TC, et al. Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. AIDS 2000;14:2371-81.
13. Vernazza PL, Eron JJ, Fiscus SA, et al. Sexual transmission of HIV: infectiousness and prevention. AIDS 1999;13:155-66.
14. Weiss HA, Quigley MA, Hayes RJ. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS 2000;14:2361-70.
15. Cu-Uvin S, Caliendo AM, Reinert S, et al. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS 2000;14:415-21.
16. Eron JJ, Smeaton LM, Fiscus SA, et al. The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS Clinical Trials Group Protocol 850). J Infect Dis 2000;181:1622-8.
17. Mayer KH, Boswell S, Goldstein R, et al. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clin Infect Dis 1999;28:1252-9.
18. Cohen MS, Anderson DJ. Genitourinary mucosal defenses. In: Holmes KK, Sparling PF, Mardh P-A, et al, editors. Sexually transmitted diseases. 3rd edition. New York: McGraw-Hill; 1999. p. 173-90.
19. Pudney J, Anderson DJ. Human male genital tract immunity and experimental models. In: Ogra PL, Mestecky J, Lamm ME, et al, editors. Mucosal immunology. 2nd edition. New York: Academic Press; 1999. p. 1411-22.
20. Kutteh WH. Mucosal immunity in the human female reproductive tract. In: Ogra PL, Mestecky J, Lamm ME, et al, editors. Mucosal immuology. 2nd edition. New York: Academic Press; 1999. p, 1423-34.
21. Pudney J, Quayle A, Anderson DJ. Localization of T cell subsets and antigen presenting cells in the lower female genital tract. (Submitted for publication).
22. Musey L, Hu Y, Eckert L, et al. HIV-1 induces cytotoxic T lymphocytes I the cervix of infected women. J Exp Med 1997;185(2):293-303.
23. Quayle AJ, Coston WMP, Trocha AK, et al. Detection of HIV-1 specific CTLs in the semen of HIV-infected individuals. J Immunol 1998;161:4406-10.
24. Belec L, Dupre T, Prazuck T, et al. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J Infect Dis 1995;172:691-7.
25. Haimovici F, Mayer KH, Anderson DJ. Quantitation of HIV-1 specific IgG, IgA and IgM antibodies in human genital tract secretions. J Acquir Immune Defic Syndr 1997;15:185-91.
26. Ghys PD, Belec L, Diallo MO, et al. Cervicovaginal anti-HIV antibodies in HIV-seronegative female sex workers in Abidjan, Cote d'Ivoire. AIDS 2000;14:1603-2608.
27. Kaul R, Trabattoni D, Bwayo JJ, et al. HIV-1 specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999;13:23-9.
28. Coombs RW, Speck CE, Hughes JP, et al. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis 1998; 177:320-30.
29. Dyer JR, Kazembe P, Vernazza PL, et al. High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in Sub-Saharan Africa. J Infect Dis 1998;177: 1742-6.
30. Evans JS, Dolan MJ, Walter EA, et al. Correlates of HIV-1 detection by viral load and culture in semen [abstract 189]. Presented at the 5th Conference on Retroviruses and Opportunistic Infection. Washington, DC, 1998.
31. Gupta P, Mellors J, Kingsley L, et al. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. J Virol 1997;71:6271-5.
32. Araneta MRG, Mascola L, Eller A, et al. HIV transmission through donor artificial insemination. JAMA 1995;273:854-8.
33. Chiasson MA, Stoneburner RL, Joseph SC. Human immunodeficiency virus transmission through artificial insemination. J Acquir Immune Defic Syndr 1990;3:69-72.
34. De Vincenzi I. Longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 1994;331(6):341-6.
35. Anderson DJ, O'Brien TR, Politch JA, et al. Effects of disease stage and zidovudine therapy on the detection of HIV-1 in semen. JAMA 1992;267:2769-74.
36. Krieger JN, Nirapathpongporn A, Chaiyaporn M, et al. Vasectomy and human immunodeficiency virus type 1 in semen. J Urol 1998;159:820-5.
37. Anderson DJ. Mechanisms of HIV-1 transmission via semen. Journal of NIH Research 1992;4:106-8.
38. Piomboni P, Baccetti B. Spermatozoon as a vehicle for HIV-1 and other viruses: a review. Mol Reprod Dev 2000;56(suppl):238-42.
39. Reichelderfer PS, Coombs RW, Wright DJ, et al. Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. AIDS 2000;14:2101-7.
40. Hu J, Gardner MB, Miller CJ. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol 2000;74:6087-95.
41. Spira AI, Marx PA, Patterson BK, et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996;183:215-25.
42. Zhang Z, Schuler T, Zupancic M, et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 1999;286:1353-7.
43. Pomerantz R, de la Monte S, Donegan C, et al. Human immunodeficiency virus (HIV) infection of uterine cervix. Ann Intern Med 1988;108:321-7.
44. Bhoopat L, Eiangleng L, Rugpao S, et al. In vivo identification of Langerhans and related dendritic cells infected with HIV-1 subtype E in vaginal mucosa of asymptomatic patients. Mod Pathol 2001;14:1263-9.
45. Farrar DJ, Cu-Uvin S, Caliendo A, et al. Detection of HIV-RNA in vaginal secretions of HIV-1 seropositive women who have undergone hysterectomy. AIDS 1997;11:1296-7.
46. Phillips DM, Zacharopoulos VR, Tan X, et al. Mechanisms of sexual transmission of HIV: does HIV infect intact epithelia? Trends Microbiol 1994;2:454-8.
47. Dezzutti CS, Guenthner PC, Cummins JE, et al. Cervical and prostate epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J Infect Dis 2001; 183:1204-13.
48. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med 1997;3:42-7.
49. Howell AL, Edkins RD, Rier SE, et al. Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower female reproductive tract. J Virol 1997;71:3498-506.
50. Kunz G, Beil D, Deninger H, et al. The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hysterosalpingoscintigraphy. Hum Reprod 1996;11:627-32.
51. Speck CE, Coombs RW, Koutsky LA, et al. Risk factors for HIV-1 shedding in semen. Am J Epidemiol 1999;150:622-31.
52. Xu C, Politch JA, Tucker L, et al. Factors associated with increased levels of HIV-1 DNA in semen. J Infect Dis 1997;176:941-7.
53. Moss GB, Overbaugh J, Welch M, et al. Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 cell depletion. J Infect Dis 1995;172:1469-74.
54. Eron JJ, Filliam B, Fiscus S, et al. HIV-1 shedding and chlamydial urethritis. JAMA 1996;275: 36-7.
55. Hobbs MM, Kazembe P, Reed AW, et al. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis 1999;26:381-7.
56. Kreiss J, Willerford DM, Hensel M, et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis 1994;170:1597-601.
57. Clemetson DB, Moss GB, Willerford DM, et al. Detection of HIV-DNA in cervical and vaginal secretions: prevalence and correlates among women in Nairobi, Kenya. JAMA 1993;269: 2860-4.
58. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-to-female transmission of human immunodeficiency virus type-1. J Infect Dis 1991;163:233-9.
59. Beck EJ, Mandalia S, Leonard K, et al. Case-control study of sexually transmitted diseases as cofactors for HIV-1 transmission. International Journal of STD and AIDS 1996;7:34-8.
60. Grosskirth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995;346: 530-6.
61. Wawer MJ, Gray RH, Sewankambo NK, et al. A randomized community trial of intensive sexually transmitted disease control AIDS prevention, Rakai, Uganda. AIDS 1998;12:1211-25.
62. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κ B. Proc Natl Acad Sci U S A 1989;86:2336-40.
63. Ho JL, He S, Hu A, et al. Neutrophils from human immunodeficiency virus (HIV) seronegative donors induce HIV replication from HIV-infected patients' mononuclear cells and cell lines: an in vitro model of HIV transmission facilitated by Chlamydia trachomatis. J Exp Med 1995; 181:1493-505.
64. Legrand-Poels S, Vaira D, Pincemail J, et al. Activation of human immunodeficiency virus type 1 by oxidative stress. AIDS Res Hum Retroviruses 1990;6:1389-97.
65. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
66. Cohen CR, Plummer FA, Mugo N, et al. Increased interleukin-10 in the endocervical secretions of women and non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? AIDS 1999;13:327-32.
67. Royce RA, Thorp J, Granados JL, et al. Bacterial vaginosis associated with HIV infection in pregnant women from North Carolina. J Acquir Immune Defic Syndr 1999;20:382-6.
68. Taha TE, Gray RH, Kumwenda NI, et al. HIV infection and disturbances of vaginal flora during pregnancy. J Acquir Immune Defic Syndr 1999;20:52-9.
69. Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999;180:1863-8.
70. Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 1998;12:1699-706.
71. Al-Harthi L, Spear GT, Hashemi FB, et al. Immunodeficiency Virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the NF-κB enhancer. J Infect Dis 1998;178:1343-51.
72. Al-Harthi L, Roebuck KA, Olinger GG, et al. Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression. J Acquir Immune Defic Syndr 1999; 21:194-202.
73. Olinger GC, Hashemi FB, Sha BE, et al. Association of indicators of bacterial vaginosis with a female genital tract factor that induces expression of HIV-1. AIDS 1999;13:1905-12.
74. Mattsby-Baltzer I, Platz-Christensen JJ, Hosseini N, et al. IL-1beta, IL-6, TNFα, fetal fibroectin, and endotoxin in the lower genital tract of pregnant women with bacterial vaginosis. Acta Obstet Gynecol Scand 1998;77:701-6.
75. Platz-Christensen JJ, Mattsby-Baltzer I, Thomsen P, et al. Endotoxin and interleukin-1 α in the cervical mucus and vaginal fluid of pregnant women with bacterial vaginosis. Am J Obstet Gyn 1993;196:1161-6.
76. John GC, Nduati RW, Mbori-Ngacha D, et al. Genital shedding of HIV-1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997;175:57-62.
77. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1998;351:213-4.
78. Mishell DR, Davajan V. Infertility, contraception and reproductive endocrinology. Oradell, NJ: Medical Economics Books; 1986.
79. O'Malley B, Strott C. Steroid hormones: metabolism and mechanism of action. In: Yen S, Jaffee R, Barbieri R, editors. Reproductive endocrinology. 4th edition. Philadelphia: WB Saunders; 1999. p. 110-33.
80. Katzenellenbogen BS. Biology and receptor interactions of estriol and estriol derivatives in vitro and in vivo. J Steroid Biochem 1984;20:1033-7.
81. Batra S, Bengtsson LP, Sjoberg NO. Interrelations between plasma and tissue concentrations of 17-β-estradiol and progesterone during human pregnancy. Clin Endocrinol 1979;11: 603-10.
82. Tulchinsky D, Hobel CJ. Plasma human chorionic gonadotropin, estrogen, estradiol, estriol, progesterone and 17 α-hydroxyprogesterone in human pregnancy. Am J Obstet Gynecol 1973; 117:884-93.
83. Villanueva JM, Ellerbrock TV, Lennox JL, et al. The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions. J Infect Dis 2002;185:170-7.
84. Martin HL, Nyange PM, Richardson BA, et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of HIV-1. J Infect Dis 1998;178:1053-9.
85. Ungchusak K, Rehle T, Thammapornpilap P, et al. Determinants of HIV infection among female commercial sex workers in northeastern Thailand: results from a longitudinal study. J Acquir Immune Defic Syndr 1996;12:500-7.
86. Marx P, Spira A, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996;2(10):1084-9.
87. Smith SM, Baskin GB, Marx PA. Estrogen protects against vaginal transmission of SIV. J Infect Dis 2000;182:708-15.
88. Vassiliadou N, Tucker L, Anderson DJ. Progesterone-induced inhibition of chemokine receptor expression on peripheral blood mononuclear cells correlates with reduced HIV-1 infectability in vitro. J Immunol 1999;162:7510-8.
89. Patterson B, Landay A, Andersson J, et al. Repertoire of chemokine receptor expression in the female genital tract. Am J Pathol 1998;153:481-90.
90. Wang CC, Reilly M, Kreiss JK. Risk of HIV infection in oral contraceptive pill users: a meta-analysis. J Acquir Immune Defic Syndr 1999;12:51-8.
91. Stephenson JM. Systematic review of hormonal contraception and risk of HIV transmission: when to resist meta-analysis. AIDS 1998;12:545-53.
92. American Society for Reproductive Medicine. Special considerations regarding human immunodeficiency virus and assisted reproductive technologies. Fertil Steril 1994;62(suppl):85S.
93. Ethics Committee of the American Society of Reproductive Medicine. Human immunodeficiency virus and infertility treatment. Fertil Steril 2002;77:218-22.
94. Gilling-Smith C. Assisted reproduction in HIV-discordant couples. AIDS Read 2000;10:581-7.
95. Anderson DJ, Politch JA, Oneta M, et al. Efficacy of conventional semen processing techniques in separation of motile sperm from HIV-1 and HIV-1 host cells. Presented at the 48th Annual Meeting of the American Fertility Society. New Orleans, 1992.
96. Semprini AE, Levi-Setti P, Bozzo M, et al. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 1992;340:1317-9.
97. Marina S, Marina F, Alcolea R, et al. Human immunodeficiency virus type 1-serodiscordant couples can bear healthy children after undergoing intrauterine insemination. Fertil Steril 1998; 70:35-9.
98. Politch JA, Xu C, Tucker L, et al. Separation of HIV-1 from motile sperm fraction: comparison of gradient/swim-up and double tube techniques [abstract O-130]. In: Programs and abstracts of the 57th annual meeting of the American Society for Reproductive Medicine. Orlando: 2001. p. S49.
99. Kaneko S, Oshio S, Kobanawa K, et al. Purification of human sperm by a discontinuous Percoll density gradient with an inner column. Biol Reprod 1986;35:1059-63.
100. Sun L-S, Gastaldi C, Peterson EM, et al. Comparison of techniques for the selection of bacteriafree sperm preparations. Fertil Steril 1987;48:659-63.
101. Levy R, Tardy JC, Bourlet T, et al. Transmission risk of hepatitis C virus in assisted reproductive techniques. Hum Reprod 2000;15:810-6.
102. McKee TA, Avery S, Majid A, et al. Risks for transmission of hepatitis C virus during artificial insemination. Fertil Steril 1996;66:161-3.
103. Semprini AE, Persico T, Savasi V, et al. Semen washing in ART for uninfected women with HIV-positive partners [abstract O-043]. Fertil Steril 2000;74(suppl):S15-6.
104. Weigel M, Gentili M, Beichart M, et al. Reproductive assistance to HIV-discordant couples the German approach. Eur J Med Res 2001;6:259-62.
105. Marina, S. Roundtable session. Presented at the 4th International Symposium on AIDS and Reproduction. Genoa, Italy, 2001.
106. Fichorova RN, Tucker LD, Anderson DJ. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to HIV-1 transmission. J Infect Dis 2001;184:418-28.
107. Stephenson J. Widely used spermicide may increase, not decrease, risk of HIV transmission. JAMA 2000;284:949.
108. Pauwels R, DeClerq E. Development of vaginal microbicides for the prevention of heterosexual transmission of HIV. J Acquir Immune Defic Syndr 1996;11:211-21.
109. Harrison PF. Microbicides: Forging scientific and political alliances. AIDS Patient Care and STDs 2000;14:199-205.
110. Irvin JD, Uckun FM. Pokeweed antiviral protein: ribosome inactivation and therapeutic applications. Pharmacol Ther 1992;55:279-302.
111. D'Cruz OJ, Uckun FM. Pokeweed antiviral protein: a potential nonspermicidal prophylactic antiviral agent. Fertil Steril 2001;75:106-14.
112. D'Cruz OJ, Uckun FM. Effect of pretreatment of semen with pokeweed antiviral protein on pregnancy outcome in the rabbit model. Fertil Steril 2001;76:830-3.
113. Dolin R. HIV vaccines for prevention of infection and disease in humans. Infect Dis Clin North Am 2000;14:1001-16.
114. Krieger JN, Coombs RW, Collier AC, et al. Seminal shedding of human immunodeficiency virus type 1 and human cytomegalovirus: evidence for different immunologic controls. J Infect Dis 1995;171:1018-22.
115. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 1997;349:1868-73.
116. Mermin JH, Holodniy M, Katzenstein DA, et al. Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction. J Infect Dis 1991;164:769-72.
117. Baccetti B, Benedetto A, Burrini AG, et al. HIV particles in spermatozoa of patients with AIDS and their transfer into the oocyte. J Cell Biol 1994;127:903-14.
118. Scofield VL, Rao B, Broder S, et al. HIV interaction with sperm. AIDS 1994;8:1733-6.
119. Quayle AJ, Xu C, Mayer KH, et al. T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis 1997; 176:960-8.
120. Lasheeb AS, King J, Ball JK, et al. Semen characteristics in HIV-1 positive men and the effect of semen washing. Genitourin Med 1997;73:303-5.
121. Tachet A, Dulioust E, Salmon D, et al. Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS 1999;13:823-31.
122. Kim LU, Johnson MR, Barton S, et al. Evaluation of sperm washing as a potential method of reducing HIV transmission in HIV-discordant couples wishing to have children. AIDS 1999; 13:645-51.
123. Hanabusa H, Kuji N, Kato S, et al. An evaluation of semen processing methods for eliminating HIV-1. AIDS 2000;14:1611-6.
124. Chrystie IL, Mullen JE, Braude PR, et al. Assisted conception in HIV discordant couples: evaluation of semen processing techniques in reducing HIV viral load. J Reprod Immunol 1998;41:301-6.
125. Pasquier C, Daudin M, Righi L, et al. Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children. AIDS 2000;14:2093-9.
126. Heimerl H, Zumbusch R, Gurtler L, et al. Which cell type in semen is the major source of HIV-DNA [abstract PO-B20-1882]? Programs and abstracts of the International Conference on AIDS 1993;9:449.
127. Weigel M, Beichart M, Gentili M, et al. Assisted reproduction of HIV-negative women with "washed" spermatozoa of HIV-positive partners-a safe procedure or merely a risk reduction method [abstract O-106]? Hum Reprod 2000;1:41-2.
128. Semprini AE. Viral transmission in ART: risks for patients and healthcare providers [abstract O-170]. Hum Reprod 2000;15:69.
129. Tur R, Veiga A, Busquets A, et al. Artificial insemination with processed sperm samples from serodiscordant couples for HIV-1. Hum Reprod 1999;14:208.
130. Gilling-Smith C. Roundtable session. Presented at the 4th International Symposium on AIDS and Reproduction. Genoa, Italy, 2001.
131. Vemazza PL. Roundtable session. Presented at the 4th International Symposium on AIDS and Reproduction. Genoa, Italy, 2001.
132. Sonnenberg-Schwan U, Weigel M. Assisted reproduction in HIV-discordant couples-the German approach. Presented at the 4th International Symposium on AIDS and Reproduction. Genoa, Italy, 2001.
133. Bujan L. Reproduction, laboratory and HIV-1. Presented at the 4th International Symposium on AIDS and Reproduction. Genoa, Italy, 2001.
134. Semprini AE, Vucetich A, Oneta M, Savasi V, et al. IVF-ET with processed semen of HIV-positive males in infertile HIV-discordant couples [abstract O-103]. Fertil Steril 1999; 72(3, Suppl 1):S40.
135. Jouannet P. HIV-1 and assisted reproductive technologies. Presented at the 4th International Symposium on AIDS and Reproduction. Genoa, Italy, 2001.
136. Loutradis D, Drakakis P, Kallianidis K, et al. Birth of two infants who were seronegative for human immunodeficiency virus type 1 (HIV-1) after intracytoplasmic injection of sperm from HIV-1-seropositive men. Fertil Steril 2001;75:210-2.